XT
CANF

XTX Topco’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

XTX Topco’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-934
Closed -$3.74K – 3878
2025
Q4 		$3.74K Buy
+934
New +$7.32K ﹤0.01% 3245
2025
Q2 		– Sell
-764
Closed -$22.6K – 2416
2025
Q1 		$22.6K Buy
+764
New +$24.4K ﹤0.01% 2118
2021
Q2 		– Sell
-56
Closed -$28K – 831
2021
Q1 		$28K Buy
+56
New +$24.3K 0.01% 650

Other funds holding CANF

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

XTX Topco's CANF Position: Q1 2026 in Review

XTX Topco sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2026, closing a stake of 934 shares — an estimated $3.74K sold.

XTX Topco first reported a position in CANF in Q1 2021 and held it in 3 quarters. The position peaked at $28K in Q1 2021. 14 funds tracked by Wall St. Rank hold CANF as of Q1 2026.

  • XTX Topco reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 934 Can-Fite BioPharma American Depositary Shares shares in Q1 2026, an estimated $3.74K.
  • XTX Topco first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2021 and held it in 3 quarters.
  • XTX Topco's Can-Fite BioPharma American Depositary Shares position peaked at $28K in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.